Better Therapeutics, Inc. (BTTX) vs CERo Therapeutics Holdings, Inc. (CERO)

Better Therapeutics, Inc. and CERo Therapeutics Holdings, Inc. are both Biotechnology companies. Better Therapeutics, Inc. is the larger, with a market value of $850.0K against $140.0K — 6.1× the size. Better Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; CERo Therapeutics Holdings, Inc. trades at 0.0×. Across the 8 metrics below, Better Therapeutics, Inc. leads on 6 and CERo Therapeutics Holdings, Inc. on 2.

Valuation

Metric BTTX CERO Biotechnology median
P/E n/m 0.00 7.88
P/S n/m n/m 11.47
P/B n/m n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield 0.00% 300,221.00% (28.84%)
Free cash flow yield 0.00% (2,869.14%) (23.03%)

Profitability

Metric BTTX CERO Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 2,351.81% 453.76% (57.72%)
Return on assets (162.15%) (2,352.32%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BTTX CERO Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 45.66% 92.12% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric BTTX CERO Biotechnology median
Debt to equity (1.44) (0.02) 0.00
Current ratio 0.57 0.05 4.73
Net debt to EBITDA 0.02 0.10 0.96

Dividend

Metric BTTX CERO Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric BTTX CERO Biotechnology median
Market cap 850.00k 140.00k 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack